In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Others say there’s not yet enough evidence to recognize severe COVID as an independent risk factor. Statistics about how widespread long COVID is vary, with the Centers for Disease Control and ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

A new review of more than 4,300 studies found full vaccination before a SARS-CoV-2 infection could reduce the risk of long COVID by 27 per cent relative to no vaccination for the general adult ...

Excess weight and obesity were significantly associated with long COVID-related neurological and neuropsychiatric symptoms, a systematic review and meta-analysis showed.The findings build upon prior ...

Others worried that exempting healthy adults might make long Covid more common ... vaccine recommendations for this coming fall and winter favored risk-based recommendations, though they don ...

No evidence was observed among adult and pediatric patients across 3 large cohorts to suggest reduced risk for long COVID over time, indicating long COVID remains an ongoing public health concern.